---
figid: PMC4868686__oncotarget-07-5289-g006
figtitle: VE-cadherin cleavage by ovarian cancer microparticles induces Beta-catenin
  phosphorylation in endothelial cells
organisms:
- Bos taurus
- Capra hircus
- Lareunionomyces loeiensis
- Triticum aestivum
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Bos taurus
- Capra hircus
- Homo sapiens
- Danio rerio
pmcid: PMC4868686
filename: oncotarget-07-5289-g006.jpg
figlink: /pmc/articles/PMC4868686/figure/F6/
number: F6
caption: 1. In absence of OCC-MPs, integrins, αV and β3 subunits present on the EC
  membrane, remain inactivated 2. OCC-MPs interact with integrins through lactadherin,
  expressed by EC, and phosptidylserine (PS) present on OCC-MPs surface. 3. Internalization
  of OCC-MP into the EC creates 2 different activations, (i) Extracellularly, metallprotinase
  matrix of the OCC-MP destructs VE-Cadherin in the adherent junction and leads to
  the translocalization of β-catenin from the membrane to the cytoplasm. (ii) Intracellularly,
  OCC-MP activates Rac1, which induces polymerization of the stress fibers and the
  further phosphorylation of β-catenin 4. Free β-catenin accumulates in the cytoplasm
  5. β-catenin is phosphorylated by PAK1/Rac1 pathway on 2 phosphorylation sites Ser552-Ser675
  and by Akt on the phosphorylation site Ser552. 6. The phosphorylated β-catenin is
  translocated to the nucleus where it interacts with the transcription factors TCF/LEF1.
  7. The interaction with TCF/LEF1 leads to the up-regulation of Wnt/β-catenin target
  genes and the mesenchymal markers. This activation promotes proliferation, migration
  and tube formation. In the off state of Wnt/β-catenin pathway, the destruction complex
  (APC, Axin, GSK3 and CK1) in the cytoplasm binds and phosphorylates β-catenin at
  2 phosphorylation sites Ser33-37 and T41-S45. β-catenin is then ubiquinated and
  degraded by proteasomes.
papertitle: VE-cadherin cleavage by ovarian cancer microparticles induces β-catenin
  phosphorylation in endothelial cells.
reftext: Hamda Al Thawadi, et al. Oncotarget. 2016 Feb 2;7(5):5289-5305.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8016406
figid_alias: PMC4868686__F6
figtype: Figure
redirect_from: /figures/PMC4868686__F6
ndex: 6507022f-df2a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4868686__oncotarget-07-5289-g006.html
  '@type': Dataset
  description: 1. In absence of OCC-MPs, integrins, αV and β3 subunits present on
    the EC membrane, remain inactivated 2. OCC-MPs interact with integrins through
    lactadherin, expressed by EC, and phosptidylserine (PS) present on OCC-MPs surface.
    3. Internalization of OCC-MP into the EC creates 2 different activations, (i)
    Extracellularly, metallprotinase matrix of the OCC-MP destructs VE-Cadherin in
    the adherent junction and leads to the translocalization of β-catenin from the
    membrane to the cytoplasm. (ii) Intracellularly, OCC-MP activates Rac1, which
    induces polymerization of the stress fibers and the further phosphorylation of
    β-catenin 4. Free β-catenin accumulates in the cytoplasm 5. β-catenin is phosphorylated
    by PAK1/Rac1 pathway on 2 phosphorylation sites Ser552-Ser675 and by Akt on the
    phosphorylation site Ser552. 6. The phosphorylated β-catenin is translocated to
    the nucleus where it interacts with the transcription factors TCF/LEF1. 7. The
    interaction with TCF/LEF1 leads to the up-regulation of Wnt/β-catenin target genes
    and the mesenchymal markers. This activation promotes proliferation, migration
    and tube formation. In the off state of Wnt/β-catenin pathway, the destruction
    complex (APC, Axin, GSK3 and CK1) in the cytoplasm binds and phosphorylates β-catenin
    at 2 phosphorylation sites Ser33-37 and T41-S45. β-catenin is then ubiquinated
    and degraded by proteasomes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mp
  - Mmp9
  - Mmp2
  - Ps
  - Mfge8
  - Ctnnb1
  - Rac1
  - Apc
  - Axin1
  - Gsk3b
  - Pak1
  - Pkn1
  - Akt1
  - Cdh5
  - Myc
  - Nol3
  - Mmp13
  - Vegfa
  - Trp53
  - Ccnd1
  - Lef1
  - Tek
  - Mmp7
  - Tube1
  - Lrp5
  - MMP9
  - MMP2
  - CTNNB1
  - RAC1
  - RNASE1
  - APC
  - PAK1
  - AKT1
  - CDH5
  - MYC
  - MMP1
  - VEGFA
  - CCND1
  - LEF1
  - MMP7
  - LRP5
  - CTNND1
  - TP53
  - APRT
  - MFAP1
  - PROC
  - AXIN1
  - AXIN2
  - GSK3A
  - GSK3B
  - PKN1
  - CHKA
  - AKT2
  - AKT3
  - HNF4A
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - TP63
  - TP73
  - TEK
  - TUBE1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - mmp9
  - mmp2
  - ctnnb1
  - rac1a
  - apc
  - gsk3ba
  - gsk3ab
  - pak1
  - cki
  - elk4
  - cdh5
  - myca
  - vegfaa
  - tp53
  - ccnd1
  - lef1
  - tek
  - lrp5
  - Ser
  - Cancer
---
